91 related articles for article (PubMed ID: 7258731)
1. Myocardial protection by lidoflazine during one-hour normothermic global ischemia.
Daenen W; Flameng W
Angiology; 1981 Aug; 32(8):543-51. PubMed ID: 7258731
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotective effects of lidoflazine during 1-hour normothermic global ischemia.
Flameng W; Daenen W; Borgers M; Thone F; Xhonneux R; van de Water A; van Belle H
Circulation; 1981 Oct; 64(4):796-807. PubMed ID: 7273379
[TBL] [Abstract][Full Text] [Related]
3. Nucleoside transport inhibition mediates lidoflazine-induced cardioprotection during intermittent aortic crossclamping.
Chang-Chun C; Masuda M; Szabò Z; Szerafin T; Szècsi J; Van Belle H; Flameng W
J Thorac Cardiovasc Surg; 1992 Dec; 104(6):1602-9. PubMed ID: 1453724
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective effects of lidoflazine in extensive aorta-coronary bypass grafting.
Flameng W; Borgers M; Van der Vusse GJ; Demeyere R; Vandermeersch E; Thoné F; Suy R
J Thorac Cardiovasc Surg; 1983 May; 85(5):758-68. PubMed ID: 6601746
[TBL] [Abstract][Full Text] [Related]
5. Preservation of the ischemic canine myocardium: a comparison of hypothermia, lidoflazine, and ketanserin.
Clark NJ; Port JD; McJames SW; Stockham RJ; Stanley TH; Pace NL
J Cardiothorac Anesth; 1988 Jun; 2(3):330-40. PubMed ID: 17171869
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment with lidoflazine, a calcium-channel blocker. Useful adjunct to heterogeneous cold potassium cardioplegia.
Kates RA; Dorsey LM; Kaplan JA; Hatcher CR; Guyton RA
J Thorac Cardiovasc Surg; 1983 Feb; 85(2):278-86. PubMed ID: 6823146
[TBL] [Abstract][Full Text] [Related]
7. Myocardial protective effects of lidoflazine during ischemia and reperfusion.
Guvendik L; Hynd J; Drake-Holland A; Parker DJ
Thorac Cardiovasc Surg; 1990 Feb; 38(1):15-9. PubMed ID: 2309223
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of brain damage by lidoflazine after prolonged ventricular fibrillation cardiac arrest in dogs.
Vaagenes P; Cantadore R; Safar P; Moossy J; Rao G; Diven W; Alexander H; Stezoski W
Crit Care Med; 1984 Oct; 12(10):846-55. PubMed ID: 6488823
[TBL] [Abstract][Full Text] [Related]
9. Lidoflazine in the early stages of acute myocardial ischaemia.
Coker SJ; Fagbemi O; Parratt JR
Br J Pharmacol; 1982 Jun; 76(2):347-54. PubMed ID: 7093589
[TBL] [Abstract][Full Text] [Related]
10. Cerebral ischemia and reperfusion: prevention of brain mitochondrial injury by lidoflazine.
Rosenthal RE; Hamud F; Fiskum G; Varghese PJ; Sharpe S
J Cereb Blood Flow Metab; 1987 Dec; 7(6):752-8. PubMed ID: 3693430
[TBL] [Abstract][Full Text] [Related]
11. [Protective effects of lidoflazine and mioflazine in ischemic myocardium].
Liu GS; Borgers M; Xhonneux R
Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Apr; 16(2):100-2, 127. PubMed ID: 3197595
[No Abstract] [Full Text] [Related]
12. Cardioprotective effects of mioflazine during 1 h normothermic global ischaemia in the canine heart.
Flameng W; Xhonneux R; Van Belle H; Borgers M; Van de Water A; Wouters L; Wijnants J; Thoné F; Van Daele P; Janssen PA
Cardiovasc Res; 1984 Sep; 18(9):528-37. PubMed ID: 6467270
[TBL] [Abstract][Full Text] [Related]
13. Mioflazine, a potentially protective drug against ischaemic damage: a study in dogs.
Wood AJ; Isted K; Hynd J; Main MJ; Noble MI; Parker J; Drake-Holland AJ
Eur Heart J; 1985 Aug; 6(8):695-701. PubMed ID: 4054139
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and ergometric studies on the effectiveness of lidoflazine in the treatment of chronic ischemic heart disease].
Teichmann W; Vogel HC; Schäbitz J; Schmeisser M; Lukesch KH
Z Gesamte Inn Med; 1976 Mar; 31(6):161-6. PubMed ID: 941465
[TBL] [Abstract][Full Text] [Related]
15. Lidoflazine does not improve neurologic outcome when administered after complete cerebral ischemia in primates.
Fleischer JE; Lanier WL; Milde JH; Michenfelder JD
J Cereb Blood Flow Metab; 1987 Jun; 7(3):366-71. PubMed ID: 3584269
[TBL] [Abstract][Full Text] [Related]
16. Early amelioration of neurologic deficit by lidoflazine after fifteen minutes of cardiopulmonary arrest in dogs.
Winegar CP; Henderson O; White BC; Jackson RE; O'Hara T; Krause GS; Vigor DN; Kontry R; Wilson W; Shelby-Lane C
Ann Emerg Med; 1983 Aug; 12(8):471-7. PubMed ID: 6881642
[TBL] [Abstract][Full Text] [Related]
17. Reduction of ischemic myocardial damage in the dog by lidocaine infusion.
Schaub RG; Stewart G; Strong M; Ruotolo R; Lemoie G
Am J Pathol; 1977 May; 87(2):399-414. PubMed ID: 851172
[TBL] [Abstract][Full Text] [Related]
18. The effect of lidoflazine on ventricular ectopic activity in chronic ischaemic heart disease.
Myburgh DP
S Afr Med J; 1975 Nov; 49(50):2087-90. PubMed ID: 1198246
[TBL] [Abstract][Full Text] [Related]
19. Myocardial depression after elective ischemic arrest. Subcellular biochemistry and prevention.
Gillette PC; Pinsky WW; Lewis RM; Bornet EP; Wood JM; Entman ML; Schwartz A
J Thorac Cardiovasc Surg; 1979 Apr; 77(4):608-18. PubMed ID: 423595
[TBL] [Abstract][Full Text] [Related]
20. Effect of lidoflazine on cerebral blood flow following twelve minutes total cerebral ischemia.
Dean JM; Hoehner PJ; Rogers MC; Traystman RJ
Stroke; 1984; 15(3):531-5. PubMed ID: 6427983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
